Back to Market Feed

Product Information

STRIVERDI RESPIMAT INHAL SPRAY is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $65.9484 per GM under NDC 00597019261. Its NADAC has been published 601 times since Feb 18, 2015.

FDA first approved this application on Jul 31, 2014.

STRIVERDI RESPIMAT INHAL SPRAY

olodaterol respimat inhalation spray
$65.9484per GM

Strength

2.5 ug/1

NDC

00597019261

Classification

Brand

Dosage Form

SPRAY, METERED

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Active Ingredients

OLODATEROL HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA203108

FDA Approved

7/31/2014

On Market Since

8/1/2014

Pharmacological Classes

Adrenergic beta2-Agonists
beta2-Adrenergic Agonist

Price Statistics

The NADAC for STRIVERDI RESPIMAT INHAL SPRAY has been published 601 times since Feb 18, 2015, and over the history we have for it it has risen 75.9%. The table below summarizes its recorded NADAC range and movement.

Current price$65.9484 per GM
All-time high$66.0840 (Jul 15, 2026)
All-time low$37.4885 (Feb 18, 2015)
52-week high$66.0840
52-week low$64.0085
Median price$54.7315
Average price$53.0362
Largest weekly change+8.0% (Apr 13, 2016)
Weeks tracked601
Tracking sinceFeb 18, 2015

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

-0.1%

1Y

+2.9%

3Y

+9.6%

5Y

+17.9%

All

+75.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olodaterol respimat inhalation spray market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

ADVAIR 100-50 DISKUS
Brand
00173069500•GlaxoSmithKline LLC
$2.4861
per EA
VENTOLIN HFA 90 MCG INHALER
Brand
00173068224•GlaxoSmithKline LLC
$2.7195
per GM
VENTOLIN HFA 90 MCG INHALER
Brand
00173068220•GlaxoSmithKline LLC
$3.0351
per GM
ADVAIR 250-50 DISKUS
Brand
00173069604•GlaxoSmithKline LLC
$3.1083
per EA
ADVAIR 250-50 DISKUS
Brand
00173069600•GlaxoSmithKline LLC
$3.1226
per EA
ADVAIR 500-50 DISKUS
Brand
00173069700•GlaxoSmithKline LLC
$4.2272
per EA
XOPENEX HFA 45 MCG INHALER
Brand
27437005601•Lupin Pharmaceuticals Inc.
$4.9891
per GM
BREO ELLIPTA 200-25 MCG INHALR
Brand
00173088214•GlaxoSmithKline LLC
$5.3573
per EA
BREO ELLIPTA 100-25 MCG INHALR
Brand
00173085914•GlaxoSmithKline LLC
$5.3594
per EA
BREO ELLIPTA 50-25 MCG INHALER
Brand
00173091610•GlaxoSmithKline LLC
$6.4829
per EA

Frequently asked questions

What is the NADAC price of STRIVERDI RESPIMAT INHAL SPRAY?

The current National Average Drug Acquisition Cost (NADAC) for STRIVERDI RESPIMAT INHAL SPRAY, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $65.9484 per GM (NDC 00597019261), effective Aug 19, 2026.

How has the price of STRIVERDI RESPIMAT INHAL SPRAY changed over time?

Over the history we have for it, the NADAC for STRIVERDI RESPIMAT INHAL SPRAY has risen 75.9%. It has been tracked across 601 weekly CMS publications since Feb 18, 2015.

What are the highest and lowest recorded NADAC prices for STRIVERDI RESPIMAT INHAL SPRAY?

Since Feb 18, 2015, the NADAC for STRIVERDI RESPIMAT INHAL SPRAY has ranged from a low of $37.4885 (Feb 18, 2015) to a high of $66.0840 (Jul 15, 2026), with a median of $54.7315 per GM.

Are there cheaper alternatives to STRIVERDI RESPIMAT INHAL SPRAY?

No other NADAC-published product currently shares the active ingredient and strength of STRIVERDI RESPIMAT INHAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures STRIVERDI RESPIMAT INHAL SPRAY?

STRIVERDI RESPIMAT INHAL SPRAY (NDC 00597019261) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.